Integra LifeSciences Holdings CorporationIART has finally come up with the news of completing Codman Neurosurgery business acquisition from Johnson & Johnson JNJ. This development was expected at the ...
Medical device maker Integra LifeSciences Holdings Corp said on Wednesday it has offered to buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash. Integra, which makes ...
Integra LifeSciences Holdings Corp. said Wednesday that it was paying $1.05 billion in cash to buy Johnson & Johnson's Codman Neurosurgery business. Codman's devices are focused on hydrocephalus, ...
Integra LifeSciences Holdings CorporationIART recently signed a definitive agreement to sell the company's certain neurosurgery assets to healthcare products and services provider Natus Medical ...
PLAINSBORO, N.J., April 11, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it will feature its ...
Integra Lifesciences ((IART)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
WASHINGTON (Reuters) - Medical device maker Integra LifeSciences Holdings Corp has received U.S. antitrust approval to buy Johnson & Johnson's Codman Neuro Division, the Federal Trade Commission said ...
(Reuters) - Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash, to expand its presence outside the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback